Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.
Neuhaus
B
B
Department of Surgery, University Clinic Rudolf Virchow, Free University Berlin, Germany.
Keck
H
H
Bechstein
W O
WO
Blumhardt
G
G
Langrehr
J M
JM
Wiens
M
M
Lemmens
H P
HP
Lohmann
R
R
Schlag
H
H
Thalmann
U
U
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016031:Liver Transplantation / Q000276:immunology* / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D012189:Retrospective Studies; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D011239:Prednisolone; C079843:inolimomab; D001379:Azathioprine